Long-term Home-based Exercise for Patients With COPD: the COPDtoParis Project

NCT06235502 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-04

No results posted yet for this study

Summary

This randomised controlled trial (RCT) aims to investigate the effect of long-term, interactive home-based cycle-exercise on patients with Chronic Obstructive Pulmonary Disease (COPD) after a COPD exacerbation requiring hospitalisation. The investigators aim to investigate if patients can maintain or improve the effects of pulmonary rehabilitation in terms of walking distance, intensity of COPD symptoms, health related quality of life and Quality Adjusted Life-Years.

Participants will cycle on a pedal-exerciser in the comfort of staying in the participants' own home, whilst getting visual feedback from the 4Mvideo app. The 4Mvideo technology is a Danish designed software system, where users can cycle forward a recording of a cyclist by treading on a pedal-exerciser, thereby getting some of the experience of a real-life cycling trip at home.

The investigators will compare the clinical outcomes and daily activity levels with that of a control group consisting of COPD patients.

Conditions

  • Telerehabilitation
  • COPD
  • Quality of Life
  • Mobility Limitation

Interventions

OTHER

Home-based cycle-exercise for COPD patients

Patients will cycle in their own home using a pedal exerciser connected to the 4M-video app

OTHER

Standard of Care

Exercise at Fitness Center, home based exercise according to a programme

Sponsors & Collaborators

  • Karen Elise Jensen Foundation

    collaborator OTHER
  • Simon Fougners Hartmann Family Foundation

    collaborator UNKNOWN
  • 4Mvideo

    collaborator UNKNOWN
  • SENS Innovation Aps

    collaborator UNKNOWN
  • Aalborg University Hospital

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06235502 on ClinicalTrials.gov